CARDINAL HEALTH INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CARDINAL HEALTH INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $222.58B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $226.83B | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | $54.87B | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | $57.44B | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | $54.65B | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | $204.98B | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $50.50B | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | $51.47B | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | $49.59B | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | $181.33B | Aug 14, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.17B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $7.41B | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | $1.94B | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | $1.85B | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | $1.74B | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | $6.87B | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $1.81B | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | $1.68B | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | $1.60B | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | $6.48B | Aug 14, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.56B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $852.00M | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | $261.00M | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | $368.00M | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | ($12.00M) | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | $330.00M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $365.00M | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | ($77.00M) | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | $98.00M | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | ($938.00M) | Aug 14, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.28B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.24B | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | $369.00M | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | $505.00M | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | ($32.00M) | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | $752.00M | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $604.00M | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | ($86.00M) | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | $123.00M | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | ($607.00M) | Aug 14, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.38B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $5.00B | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | $1.27B | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | $1.27B | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | $1.19B | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | $4.80B | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | $1.17B | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | $1.18B | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | $1.20B | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | $4.51B | Aug 14, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.40B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $3.76B | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $2.84B | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $3.18B | Aug 14, 2024 |
| FY2023 | Jun 30, 2021 | $2.43B | Aug 15, 2023 |
| FY2022 | Jun 30, 2020 | $1.96B | Aug 11, 2022 |
| FY2021 | Jun 30, 2019 | $2.72B | Aug 16, 2021 |
| FY2020 | Jun 30, 2018 | $2.77B | Aug 13, 2020 |
| FY2019 | Jun 30, 2017 | $1.18B | Aug 20, 2019 |
| FY2018 | Jun 30, 2016 | $2.97B | Aug 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $547.00M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $511.00M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $481.00M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $387.00M | Aug 14, 2024 |
| FY2023 | Jun 30, 2021 | $400.00M | Aug 15, 2023 |
| FY2022 | Jun 30, 2020 | $375.00M | Aug 11, 2022 |
| FY2021 | Jun 30, 2019 | $328.00M | Aug 16, 2021 |
| FY2020 | Jun 30, 2018 | $384.00M | Aug 13, 2020 |
| FY2019 | Jun 30, 2017 | $387.00M | Aug 20, 2019 |
| FY2018 | Jun 30, 2016 | $465.00M | Aug 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $53.12B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $45.12B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $43.35B | Aug 14, 2024 |
| FY2023 | Jun 30, 2022 | $43.88B | Aug 15, 2023 |
| FY2023 | Jun 30, 2021 | $44.45B | Aug 15, 2023 |
| FY2022 | Jun 30, 2020 | $40.77B | Aug 11, 2022 |
| FY2021 | Jun 30, 2019 | $40.96B | Aug 16, 2021 |
| FY2020 | Jun 30, 2018 | $39.95B | Aug 13, 2020 |
| FY2019 | Jun 30, 2017 | $40.11B | Aug 20, 2019 |
| FY2018 | Jun 30, 2016 | $34.12B | Aug 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($2.78B) | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | ($3.21B) | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | ($2.96B) | Aug 14, 2024 |
| FY2023 | Jun 30, 2022 | ($709.00M) | Aug 15, 2023 |
| FY2022 | Jun 30, 2021 | $1.79B | Aug 11, 2022 |
| FY2021 | Jun 30, 2020 | $1.79B | Aug 16, 2021 |
| FY2020 | Jun 30, 2019 | $6.33B | Aug 13, 2020 |
| FY2019 | Jun 30, 2018 | $6.06B | Aug 20, 2019 |
| FY2018 | Jun 30, 2017 | $6.81B | Aug 22, 2018 |
| FY2017 | Jun 30, 2016 | $6.55B | Aug 10, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $9.69B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $4.73B | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $4.61B | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $5.86B | Aug 14, 2024 |
| FY2023 | Jun 30, 2021 | $7.99B | Aug 15, 2023 |
| FY2022 | Jun 30, 2020 | $8.36B | Aug 11, 2022 |
| FY2021 | Jun 30, 2019 | $8.38B | Aug 16, 2021 |
| FY2020 | Jun 30, 2018 | $8.32B | Aug 13, 2020 |
| FY2019 | Jun 30, 2017 | $7.22B | Aug 20, 2019 |
| FY2018 | Jun 30, 2016 | $7.17B | Aug 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $783.00M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | ($286.00M) | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | ($642.00M) | Aug 14, 2024 |
| FY2023 | Jun 30, 2022 | ($280.00M) | Aug 15, 2023 |
| FY2022 | Jun 30, 2021 | $1.21B | Aug 11, 2022 |
| FY2021 | Jun 30, 2020 | $1.17B | Aug 16, 2021 |
| FY2020 | Jun 30, 2019 | $5.43B | Aug 13, 2020 |
| FY2019 | Jun 30, 2018 | $4.65B | Aug 20, 2019 |
| FY2018 | Jun 30, 2017 | $4.97B | Aug 22, 2018 |
| FY2017 | Jun 30, 2016 | $6.42B | Aug 10, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.87B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $5.13B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $4.08B | Aug 14, 2024 |
| FY2023 | Jun 30, 2022 | $4.72B | Aug 15, 2023 |
| FY2022 | Jun 30, 2021 | $3.41B | Aug 11, 2022 |
| FY2021 | Jun 30, 2020 | $2.77B | Aug 16, 2021 |
| FY2021 | Jun 30, 2019 | $2.53B | Aug 16, 2021 |
| FY2021 | Jun 30, 2018 | $1.76B | Aug 16, 2021 |
| FY2020 | Jun 30, 2017 | $6.88B | Aug 13, 2020 |
| FY2019 | Jun 30, 2016 | $2.36B | Aug 20, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Jun 30, 2011 | $2.50B | Aug 26, 2011 |
| FY2010 | Jun 30, 2010 | $2.13B | Sep 2, 2010 |
| FY2010 | Jun 30, 2009 | $3.64B | Sep 2, 2010 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 6 | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | 1 | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | 1 | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | 1 | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | 1 | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | (3) | Aug 14, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 6 | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Aug 12, 2025 |
| FY2024 | Mar 31, 2024 | 1 | Aug 14, 2024 |
| FY2024 | Dec 31, 2023 | 1 | Aug 14, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Aug 14, 2024 |
| FY2025 | Jun 30, 2023 | 1 | Aug 12, 2025 |
| FY2024 | Mar 31, 2023 | 1 | Aug 14, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Aug 14, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Aug 14, 2024 |
| FY2024 | Jun 30, 2022 | (3) | Aug 14, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $494.00M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $499.00M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $525.00M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $559.00M | Aug 14, 2024 |
| FY2023 | Jun 30, 2021 | $573.00M | Aug 15, 2023 |
| FY2022 | Jun 30, 2020 | $569.00M | Aug 11, 2022 |
| FY2021 | Jun 30, 2019 | $577.00M | Aug 16, 2021 |
| FY2020 | Jun 30, 2018 | $581.00M | Aug 13, 2020 |
| FY2019 | Jun 30, 2017 | $577.00M | Aug 20, 2019 |
| FY2018 | Jun 30, 2016 | $512.00M | Aug 22, 2018 |